• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

茶碱对治疗哮喘急性发作时肺功能改善的作用:急性哮喘严重程度的影响

Effect of theophylline on improvement of the pulmonary function in the treatment of acute episodes of asthma: the influence of the severity of acute asthma.

作者信息

Sakamoto Y, Kabe J, Horai Y

机构信息

Department of Medicine and Physical Therapy, School of Medicine, University of Tokyo, Japan.

出版信息

Ann Allergy. 1989 Jul;63(1):21-7.

PMID:2742214
Abstract

The bronchodilating effect of theophylline was studied from the perspective of its influence on the severity of acute asthmatic attack and where its acting site is located on bronchi. Pulmonary function including maximal expiratory flow-volume curve breathing of room air and of a gas mixture containing 80% helium and 20% oxygen (He-O2) was measured at each incremental plasma theophylline concentration plateau (5, 10, and 15 micrograms/mL) in 12 acutely ill asthmatic patients. Before starting the administration of theophylline, clinical findings were used to classify the severity of the asthmatic attack into mild, moderate, or severe groups. Our data suggested that theophylline acts on both the central and peripheral airways and that theophylline improves the airway obstruction in a dose-dependent fashion when the severity of acute attack is mild.

摘要

从茶碱对急性哮喘发作严重程度的影响及其作用部位在支气管的何处这一角度,对其支气管扩张作用进行了研究。在12例急性哮喘患者中,于血浆茶碱浓度的每个递增稳定期(5、10和15微克/毫升)测量肺功能,包括吸入室内空气以及含80%氦气和20%氧气的混合气体(氦氧混合气)时的最大呼气流量-容积曲线。在开始给予茶碱之前,根据临床症状将哮喘发作的严重程度分为轻度、中度或重度组。我们的数据表明,茶碱作用于中央气道和外周气道,并且当急性发作程度为轻度时,茶碱以剂量依赖方式改善气道阻塞。

相似文献

1
Effect of theophylline on improvement of the pulmonary function in the treatment of acute episodes of asthma: the influence of the severity of acute asthma.茶碱对治疗哮喘急性发作时肺功能改善的作用:急性哮喘严重程度的影响
Ann Allergy. 1989 Jul;63(1):21-7.
2
Pharmacokinetics and pharmacodynamics of three sustained-release theophylline preparations (Theograd, 350 mg Theolair Retard, and 300 mg Theolin Retard) in steady state in six normals and six patients with chronic asthmatic bronchitis--Part II: Lung function.三种缓释茶碱制剂(Theograd、350毫克Theolair Retard和300毫克Theolin Retard)在6名正常人和6名慢性哮喘性支气管炎患者稳态时的药代动力学和药效学——第二部分:肺功能
Int J Clin Pharmacol Ther Toxicol. 1985 Jul;23(7):339-44.
3
The influence of ketotifen and aminophylline on the central and peripheral airways.酮替芬和氨茶碱对中央气道和外周气道的影响。
Arzneimittelforschung. 1983;33(2):265-8.
4
Restrictive impairment in patients with asthma.哮喘患者的限制性损害。
Respir Med. 2007 Feb;101(2):272-6. doi: 10.1016/j.rmed.2006.05.008. Epub 2006 Jun 22.
5
Diurnal variation of air and helium-oxygen flow-volume curves in asthmatic children.哮喘儿童空气和氦氧流量-容积曲线的日变化
Br J Dis Chest. 1982 Jan;76(1):51-6.
6
Pulmonary function in severe chronic asthma in children during apparent clinical remission.儿童重度慢性哮喘在临床明显缓解期的肺功能
Eur J Respir Dis. 1983 Oct;64(7):487-93.
7
Grading, time course, and incidence of exercise-induced airway obstruction and hyperinflation in asthmatic children.哮喘儿童运动诱发气道阻塞和肺过度充气的分级、病程及发生率
Pediatrics. 1975 Nov;56(5 pt-2 suppl):868-79.
8
[The efficacy of intravenous theophylline injection for treatment of acute exacerbations of bronchial asthma].静脉注射茶碱注射液治疗支气管哮喘急性加重的疗效
Arerugi. 2002 Apr;51(4):379-82.
9
[Evaluation of the efficacy of inhaled glucocorticosteroids in mild bronchial asthma].[吸入性糖皮质激素治疗轻度支气管哮喘的疗效评估]
Ter Arkh. 2003;75(11):64-8.
10
Computational fluid dynamics can detect changes in airway resistance in asthmatics after acute bronchodilation.计算流体动力学可以检测出哮喘患者在急性支气管扩张后气道阻力的变化。
J Biomech. 2008;41(1):106-13. doi: 10.1016/j.jbiomech.2007.07.009. Epub 2007 Aug 14.

引用本文的文献

1
Computer assisted design of a theophylline dosing regimen in acute bronchospasm: serum concentrations and clinical outcome.
Eur J Clin Pharmacol. 1992;43(1):29-33. doi: 10.1007/BF02280750.